Optimizing targeted cancer therapies and medication adherence
Optimization of Targeted Anticancer Therapies: a Systematic Collection and Modeling of Pharmacokinetic Data and Elaboration of an Adherence Program
This study is testing how well targeted cancer drugs work in the body and how to help patients stick to their medication plans to improve treatment outcomes.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 500 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Centre Hospitalier Universitaire Vaudois Academic / other |
| Locations | 1 site (Lausanne, Canton of Vaud) |
| Trial ID | NCT04484064 on ClinicalTrials.gov |
What this trial studies
This study aims to understand how targeted anticancer drugs behave in the body and how patients adhere to their medication regimens. It includes an observational component to analyze drug concentration and its effects, as well as an interventional component focused on improving adherence to oral targeted therapies. By identifying factors that influence drug levels and adherence, the study seeks to tailor treatment plans to individual patient needs, potentially enhancing efficacy and reducing toxicity. The findings could lead to more personalized cancer treatment strategies.
Who should consider this trial
Good fit: Ideal candidates are cancer patients who are prescribed targeted anticancer therapies.
Not a fit: Patients who are unable to make informed decisions or are under legal guardianship may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved treatment outcomes for cancer patients through personalized medication management.
How similar studies have performed: Other studies have shown promise in optimizing cancer treatments through personalized approaches, suggesting potential success for this study as well.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Cancer patients to whom a targeted anticancer therapy is prescribed Exclusion Criteria: * Patients incapable of judgment or participants under tutelage
Where this trial is running
Lausanne, Canton of Vaud
- Chuv — Lausanne, Canton of Vaud, Switzerland (Recruiting)
Study contacts
- Principal investigator: Chantal Csajka, PharmD, PhD — Clinical Pharmacy Sciences
- Study coordinator: Chantal Csajka, PharmD, PhD
- Email: chantal.csajka@chuv.ch
- Phone: 21 314 42 63
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.